Journals / Journal of Clinical and Analytical Medicine / 2015 / Cilt: 6 - Sayı: 1

Kısa Süreli Cerrahide Sugammadeks ile Neostigminin Karşılaştırılması

Comparison of Sugammadex and Neostigmine in Short Term Surgery

Pages
41–45
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Material and Method: After writteninformed consent, 33 patients aged 18 65, ASA I-III, who were undergoingshort term surgery (

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: This study compared the efficacy and cost effectivines of sugamma- dex and neostigmine for reversal of neuromuscular blockade induced by ro- curonium for short term elective surgery.
📊
Key Findings & Data:Aim: This study compared the efficacy and cost effectivines of sugamma- dex and neostigmine for reversal of neuromuscular blockade induced by ro- curonium for short term elective surgery.
💡
Conclusion & Impact:Material and Method: After writteninformed consent, 33 patients aged 18 65, ASA I-III, who were undergoingshort term surgery (
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: This study compared the efficacy and cost effectivines of sugamma- dex and neostigmine for reversal of neuromuscular blockade induced by ro- curonium for short term elective surgery. Material and Method: After writteninformed consent, 33 patients aged 18 65, ASA I-III, who were undergoingshort term surgery (

Özet

Amaç: Bu çalışmada kısa süreli elektif cerrahide; rokuronyumla oluşturulan nöromusküler bloğun geri döndürülmesinde sugammadeks ve neostigminin klinik etki ve maliyeti karşılaştırıldı. Gereç ve Yöntem: Yazılı onayları alındıktan sonra, ASA I-III, öngörülen cerrahi süresi 90 dakikayı aşmayan, 18-65 yaş arası 33 hasta randomize edilerek iki gruba ayrıldı (Grup Sugammadeks, n=16; Grup Neostigmin, n=17). Anestezi indüksiyonunda tüm hastalara fentanil 1-2 µg/kg, tiopental 5-7 mg/kg, rokuronyum 0,6 mg/kg verildi. İdamede % 50 O2-N2O ve % 1 sevofluran kullanıldı. Nöromusküler blok seviyesi akselomyolografi metoduyla train-o-four (TOF) stimulasyon ile monitorize edildi. Ameliyat sırasında TOF ölçümleri yapılarak TOF 3 olduğunda 0.1-0.2 mg kg ek rokuronyum yapıldı. Cerrahi sonunda TOF 2 olunca Grup Sye 2 mg/kg sugammadeks yapılırken Grup Nye 50 µg/kg neostigmin ve 20 µg/ kg atropin uygulandı. Bulgular: Gruplar arasında demografik özellikler benzerdi. TOF oranı 0,9a ulaşma ve ekstübasyon süreleri Grup Sde ve Grup Ne göre anlamlı olarak kısaydı (2,3±0,9 dk, 9,4±2,7dk ve 6,6±1,6 dk., 12.9±2 dk) (p

🔖

Cite This Article

TURAN, G., EKİNCİ, O., KOÇ, F., SUBAŞI, D. (2022). Kısa Süreli Cerrahide Sugammadeks ile Neostigminin Karşılaştırılması. Journal of Clinical and Analytical Medicine, Cilt: 6 - Sayı: 1, 41–45. https://ajindex.com/articles/561014

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Kayhan Z, editör. Klinik Anestezi İstanbul: Logos Yayıncılık; 2007.p.151-80
  2. Morgan GE, Mikhail MS, Murray MJ. Neuromuscular blocking agent. In: Morgan GE, Mikhail MS. Murray MJ, editors. Clinical Anaesthesiology. 2nd ed. Newyork: Lange Medical Books/McGraw-Hill Medical Publishing Division; 2010.p.179-98
  3. Naguib M. Pharmacology of muscle relaxant and their antagonist neuromuscu- lar physiology and pharmacology. In: Miller RD. Editor. Anaesthesia. 6th ed. Philadelphia: Churchil Livingston; 2006.p.481-572
  4. Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of proufond rocuronium induced blockade with sugammadeks a randomized comparison with neostigmine. Anesthesiology. 2008;109(5):816-24
  5. Sorgenfrei IF, Norrild K, Larsen PB, Stansballe J, Ostergaard D, Prins ME et al. Reversal of rocuronium induced neuromuscular block by the selective rela- xant binding agent sugammadeks: a dose finding and safety study. Anaesthesiology 2006;104(4): 667-74
  6. Lemmens HJ, El-Orbany MI, Berry J, Morte JB, Martin G. Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugam- madex versus neostigmine. BMC Anesthesiol. 2010; doi: 10.1186/1471-2253-10- 15
  7. Sacan O, White PF, Tufanogullari B, Klein K. Sugammadex Reversal of Rocuronium-Induced Neuromuscular Blockade: A Comparison with Neostigmine- Glycopyrrolate and Edrophonium-Atropine. Anesth Analg 2007;104(3):569-74
  8. Shields M, Giovannelli M, Mirakhur RK, Moppett I, Adams J, Hermens Y. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of pro- longed rocuronium-induced neuromuscular block. Br J Anaesth 2006;96(1):36-43
  9. Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WG, Heeringa M et al. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology 2007;106(6):283-8
  10. Blobner M, Eriksson L, Scholz J, Hillebrand H, Pompei L. Reversal of rocuronium- induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. Eur J Anaesthesiol 2010;27(10):874-81
  11. Schaller SJ, Fink H, Ulm K, Blobner M, Sugammadex and neostigmine dose- finding study for reversal of shallow residual neuromuscular block. Anesthesiology 2010;113(5):1054-60
  12. McDonagh DL, Benedict PE, Kovac AL, Drover D, Brister NW, Morte JB et al. Efficacy and safety of sugammadex for reversal of rocuronium-induced